Point72 Asset Management
VTAE

Point72 Asset Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Point72 Asset Management’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-55,074
Closed -$594K – 946
2016
Q2 		$594K Sell
55,074
-419,926
-88% -$3.59M ﹤0.01% 651
2016
Q1 		$3.15M Buy
+475,000
New +$4.32M 0.02% 505
2015
Q4 		– Sell
-594,535
Closed -$6.55M – 951
2015
Q3 		$6.55M Buy
594,535
+149,693
+34% +$1.59M 0.05% 388
2015
Q2 		$6.41M Buy
444,842
+79,842
+22% +$1.08M 0.04% 410
2015
Q1 		$4.27M Buy
+365,000
New +$4.92M 0.03% 460

Other funds holding VTAE

AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management's VTAE Position: Q3 2016 in Review

Point72 Asset Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q3 2016, closing a stake of 55,074 shares — an estimated $594K sold.

Point72 Asset Management first reported a position in VTAE in Q1 2015 and held it in 5 quarters. The position peaked at $6.55M in Q3 2015. 98 funds tracked by Wall St. Rank hold VTAE as of Q3 2016.

  • Point72 Asset Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Point72 Asset Management sold 55,074 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q3 2016, an estimated $594K.
  • Point72 Asset Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015 and held it in 5 quarters.
  • Point72 Asset Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $6.55M in Q3 2015.
  • 98 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q3 2016.

Based on Point72 Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.